Press Release from Aperio
Vista, CA – June 18, 2008 – Aperio Technologies, Inc., the leading provider of digital pathology systems and services for the healthcare and life sciences industry, announced today that Dirk Soenksen, chief executive officer, will speak at Jefferies & Company Inc.’s Healthcare Conference to be held June 26 – 28, 2008 in New York, NY.
The conference will showcase more than 170 public and private companies and industry experts to address the areas of biotechnology, CROs, healthcare services, healthcare IT, managed care, medical devices & diagnostics, and specialty pharmaceuticals. Synergies created by this combined event are intended to provide Jefferies’ institutional clients with broader access to leading companies in these areas.
The Aperio presentation will be held at 8:00 a.m. eastern time on June 26th. During his session, Mr. Soenksen will provide an overview of the digital pathology market, and discuss Aperio’s strategies for leveraging its market leadership position to capitalize on this emerging multi-billion dollar market. Listeners can access the presentation live and in replay via webcast at www.jefferies.com. The webcast will be archived at the Aperio website following the presentation.
“Jefferies’ conference features an impressive collection of healthcare and life science companies,” stated Dirk Soenksen, CEO of Aperio. “We are grateful for the opportunity to present Aperio’s digital pathology vision and strategy.”
Aperio is digitizing pathology. We provide systems and services for digital pathology, which is an environment for the management and interpretation of pathology information that originates with the digitization of a glass slide. Aperio’s award-winning ScanScope® slide scanning systems and Spectrum™ digital pathology information management software improve the efficiency and quality of pathology services for pathologists and other professionals. Applications include education, remote viewing, archival and retrieval, basic research, and image analysis. Aperio’s products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For more information, please visit www.aperio.com.